Yong Hong Xiao

Summary

Country: China

Publications

  1. doi request reprint Retrospective survey of the efficacy of mandatory implementation of the Essential Medicine Policy in the primary healthcare setting in China: failure to promote the rational use of antibiotics in clinics
    Yonghong Xiao
    Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China Electronic address
    Int J Antimicrob Agents 48:409-14. 2016
  2. doi request reprint Bacterial-resistance among outpatients of county hospitals in China: significant geographic distinctions and minor differences between central cities
    Yonghong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Initiative Center for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China Electronic address
    Microbes Infect 17:417-25. 2015
  3. pmc Changes in Chinese policies to promote the rational use of antibiotics
    Yonghong Xiao
    Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
    PLoS Med 10:e1001556. 2013
  4. doi request reprint The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China
    Yonghong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Microb Drug Resist 18:42-6. 2012
  5. ncbi request reprint [A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100191, China
    Zhonghua Nei Ke Za Zhi 50:225-9. 2011
  6. doi request reprint Epidemiology and characteristics of antimicrobial resistance in China
    Yong Hong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
    Drug Resist Updat 14:236-50. 2011
  7. ncbi request reprint Pharmacokinetics of metadoxine for injection after repeated doses in healthy volunteers
    Yuan Lu
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100083, China
    Chin Med J (Engl) 120:166-8. 2007
  8. ncbi request reprint [Clinical and laboratory problems related to the application of antibiotics]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Peking University, Beijing 100083, China
    Zhonghua Yi Xue Za Zhi 83:357-9. 2003
  9. ncbi request reprint Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers
    Yuan Lu
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100191, China
    Chin Med J (Engl) 124:242-5. 2011
  10. ncbi request reprint [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Peking University, Beijing 100038 China
    Zhonghua Yi Xue Za Zhi 84:1867-71. 2004

Collaborators

Detail Information

Publications13

  1. doi request reprint Retrospective survey of the efficacy of mandatory implementation of the Essential Medicine Policy in the primary healthcare setting in China: failure to promote the rational use of antibiotics in clinics
    Yonghong Xiao
    Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China Electronic address
    Int J Antimicrob Agents 48:409-14. 2016
    ..In conclusion, inappropriate antibiotic use is a serious problem in primary medical institutions in China. Whilst enforcing the EMP reduced the cost of medical services, it had little effect on promoting the rational use of antibiotics. ..
  2. doi request reprint Bacterial-resistance among outpatients of county hospitals in China: significant geographic distinctions and minor differences between central cities
    Yonghong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Initiative Center for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China Electronic address
    Microbes Infect 17:417-25. 2015
    ....
  3. pmc Changes in Chinese policies to promote the rational use of antibiotics
    Yonghong Xiao
    Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
    PLoS Med 10:e1001556. 2013
    ..Please see later in the article for the Editors' Summary. ..
  4. doi request reprint The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China
    Yonghong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Microb Drug Resist 18:42-6. 2012
    ..The dominant type of aminoglycoside-modifying enzyme, AAC(3)-II, might be the main source of the disparity in E. coli resistance to different aminoglycoside agents...
  5. ncbi request reprint [A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100191, China
    Zhonghua Nei Ke Za Zhi 50:225-9. 2011
    ..To evaluate the clinical efficacy and safety of antofloxacin hydrochloride tablet for the treatment of acute bacterial infections...
  6. doi request reprint Epidemiology and characteristics of antimicrobial resistance in China
    Yong Hong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
    Drug Resist Updat 14:236-50. 2011
    ..aeruginosa and extensive-resistant A. baumannii, and the antimicrobial resistance in primary healthcare and outpatient setting should be intensely monitored and investigated in the future...
  7. ncbi request reprint Pharmacokinetics of metadoxine for injection after repeated doses in healthy volunteers
    Yuan Lu
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100083, China
    Chin Med J (Engl) 120:166-8. 2007
  8. ncbi request reprint [Clinical and laboratory problems related to the application of antibiotics]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Peking University, Beijing 100083, China
    Zhonghua Yi Xue Za Zhi 83:357-9. 2003
  9. ncbi request reprint Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers
    Yuan Lu
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100191, China
    Chin Med J (Engl) 124:242-5. 2011
    ..The purpose of the study was to evaluate the pharmacokinetic characteristics of single and multiple oral doses of antofloxacin hydrochloride in Chinese healthy male volunteers...
  10. ncbi request reprint [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Peking University, Beijing 100038 China
    Zhonghua Yi Xue Za Zhi 84:1867-71. 2004
    ..To compare the pharmacokinetics/pharmacodynamics property of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections and evaluate the recommended regimens...
  11. ncbi request reprint [Impact of misuse of antimicrobial therapies on inpatient costs]
    Li Yang
    Department of Health Policy and Management, Peking University School of Public Health, Beijing 100191, China
    Beijing Da Xue Xue Bao 42:279-83. 2010
    ..To evaluate the impact of inappropriate antibiotic use on inpatients' cost during hospitalization...
  12. ncbi request reprint [Concept of pharmacokinetics/pharmacodynamics in Antibiotics and its clinical significance]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Beijing University, Beijing 100083, China
    Zhonghua Yi Xue Za Zhi 84:1914-5. 2004
  13. ncbi request reprint [Study on drug resistance and molecular epidemiology of Streptococcus pneumoniae isolated in Chongqing]
    Cheng Yao
    Department of Infectious Diseases, The First Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing 400016, China
    Zhonghua Liu Xing Bing Xue Za Zhi 26:431-4. 2005
    ..To investigate the prevalence and drug resistance of Streptococcus (S.) pneumoniae in patients infected in communities and molecular epidemiology with BOX-polymerase chain reaction (PCR) in Chongqing areas...